📰 Acceptance Priority Procedures News
Page 2 - Acceptance Priority Procedures News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Acceptance Priority Procedures. Real-time updates on events, politics, business and more.
March 3, 2022
NEW YORK--(BUSINESS WIRE)--$BMY #BMS--Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol Myers Squibb”), with its wholly-owned subsidiary Celgene Corporation (“Celgene”) (collectively, the “Offerors”), announced the accepted amounts and pricing terms of their previously announced 22 separate offers to purchase for ca...
February 17, 2022
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced the commencement of 30 separate...
December 8, 2021
/PRNewswire/ -- Petróleos Mexicanos ("PEMEX") announced today the pricing of global notes denominated in U.S. Dollars, and the commencement of liability...
December 8, 2021
/PRNewswire/ -- Petróleos Mexicanos ("PEMEX") announced today the pricing of global notes denominated in U.S. Dollars, and the commencement of liability...
December 2, 2021
/PRNewswire/ -- LyondellBasell Industries N.V. ("LyondellBasell") (NYSE: LYB) today announced, in connection with its previously announced five separate offers...
December 2, 2021
/PRNewswire/ -- LyondellBasell Industries N.V. ("LyondellBasell") (NYSE: LYB) today announced, in connection with its previously announced five separate offers...
October 26, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
February 20, 2021
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion Bristol-Myers Squibb Company with its wholly-owned subsidiary Celgene Corporation announced the accepted amounts and pricing terms of their previously announced 20 separate offers to purchase for cash notes issued by the Offerors listed in the tables below for up to an aggregate purchase price of $4.0 billion. The table below indicates, among other things, the...
February 4, 2021
Bristol Myers Squibb Announces Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion Bristol-Myers Squibb Company with its wholly-owned subsidiary Celgene Corporation announced the commencement of 20 separate offers to purchase for cash notes issued by the Offerors listed in the tables below for an aggregate purchase price of up to $4.0 billion. 2023 Pool Offers to purchase for cash up to $950,000,000 aggregate purchase price for the securities listed in the priority order below. ...